Clinical Trial Update: Ticagrelor With and Without Aspirin in Patients With Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing ticagrelor with and without aspirin in patients with Type 2 diabetes mellitus and coronary artery disease; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Aspirin (Aspirin)
• BRILINTA (ticagrelor)

Snippet

Sponsor: University of Florida | Conditions: Diabetes Mellitus, Type 2, Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2025-03-30